Compound Detail
CHEMBL4802249
LENACAPAVIR SODIUM 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
CC(C)(C#Cc1ccc(-c2ccc(Cl)c3c([N-]S(C)(=O)=O)nn(CC(F)(F)F)c23)c([C@H](Cc2cc(F)cc(F)c2)NC(=O)Cn2nc(C(F)(F)F)c3c2C(F)(F)[C@@H]2C[C@H]32)n1)S(C)(=O)=O.[Na+]
Basic Information
| ChEMBL ID | CHEMBL4802249 |
| Name | LENACAPAVIR SODIUM |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | SSXPGMNGIORJAQ-PZNXWHLTSA-M |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL4594438 |
| Active Moiety | CHEMBL4594438 |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
5
Known Names
2
Indications
1
Mechanisms
Molecular Properties
968.3
MW (Da)
7.66
ALogP
10
HBA
2
HBD
157.9
PSA (Ų)
0.10
QED
2
Ro5 Violations
11
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2022 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Structural capsid protein inhibitor | INHIBITOR | Structural capsid protein | ✓ | ✓ |
Indications
HIV Infections HIV-1
Data from ChEMBL 36 via Core Engine